Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions

NCT: NCT05750654 · COMPLETED

NCT IDNCT05750654
StatusCOMPLETED
Start Date2023-07-24
Completion2026-02-24
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the effectiveness of small phlebotomy tubes to reduce RBC transfusions in medical intensive care unit (ICU) and Intermediate care unit (IMU) patients with low hemoglobin compared with standard size tubes, to compare the intervention and the control groups in regards to: ICU length of stay (LOS), ICU mortality, hospital LOS, and hospital mortality and to assess the acceptability of small phlebotomy tubes in adult ICU and IMU patients.

Frequently Asked Questions

What is SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions?

SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions is a clinical trial registered under NCT05750654. Current status: COMPLETED.

What is the status of NCT05750654?

The current status of NCT05750654 (SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions) is: COMPLETED.

When did SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions start?

SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions started on 2023-07-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.